Taroh Satoh - Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University;Hirosaki University;Department of Internal Medicine, The University of Tokyo

基本信息

Career Trajectory

Bio

Dr. Satoh is a Professor at the Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Japan. He is a certified doctor at the Japan Society of Internal Medicine, Japanese Society of Gastroenterology and Japanese Society for Medical Oncology. He is also involved in numerous cancer drug trials in gastric cancer field:
‒ RAINBOW, RAINFALL, RAINSTORM, RINDBeRG (PI: principal investigator)
‒ Attraction-2, KEYNOTE-061, KEYNOTE-062 etc.
He has published widely in many international journals as first author of TyTAN trial and QOL analysis of ToGA trial etc. He is the leader in gastric cancer and other GI cancer field in Japan.

Research Interests

Papers共 496 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Table 2 from Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer

Tomoko Jogo, Yoshiaki Nakamura,Kohei Shitara, Hideaki Bando,Hisateru Yasui, Taito Esaki, Tetsuji Terazawa,Taroh Satoh,Eiji Shinozaki, Tomohiro Nishina, Yu Sunakawa,Yoshito Komatsu, Hiroki Hara,Eiji Oki, Nobuhisa Matsuhashi, Takashi Ohta, Takeshi Kato,Koushiro Ohtsubo, Takeshi Kawakami,Naohiro Okano, Yoshiyuki Yamamoto,Takanobu Yamada, Akihito Tsuji, Justin I. Odegaard,Hiroya Taniguchi, Toshihiko Doi, Satoshi Fujii,Takayuki Yoshino

crossref（2024）

Cited0Views0Bibtex

Supplementary Table 1 from Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer

crossref（2024）

Cited0Views0Bibtex

Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program

Daisuke Kotani,Atsuo Takashima,Takeshi Kato,Taroh Satoh,Toshiki Masuishi,Yoshito Komatsu,Manabu Shiozawa,Taito Esaki, Naoki Izawa,Shinji Takeuchi,Hideaki Bando,Satoru Iwasa,Hiroko Hasegawa,Toshifumi Yamaguchi,Hiroya Taniguchi, Yasunori Ushida, Toshiya Oizaki, Chiaki Inoue,Takayuki Yoshino

CLINICAL COLORECTAL CANCERno. 2 (2024)

Cited0Views0WOSBibtex

Supplementary Figure Legend from Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Table 3 from Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer

crossref（2024）

Cited0Views0Bibtex

Trastuzumab Deruxtecan in Advanced Solid Tumors with Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial

Masataka Yagisawa,Hiroya Taniguchi,Taroh Satoh, Shigenori Kadowaki, Yu Sunakawa, Tomohiro Nishina,Yoshito Komatsu, Taito Esaki,Daisuke Sakai,Ayako Doi,Takeshi Kajiwara,Hiromi Ono, Masatoshi Asano, Nami Hirano,Justin Odegaard, Satoshi Fujii, Shogo Nomura, Hideaki Bando,Akihiro Sato,Takayuki Yoshino, Yoshiaki Nakamura

Journal of clinical oncology official journal of the American Society of Clinical Oncologyno. 32 (2024): 3817-3825

Cited0Views0WOSBibtex

Phase II Trial of Niraparib for BRCA-mutated Biliary Tract, Pancreatic and Other Gastrointestinal Cancers: NIR-B

Yasuyuki Kawamoto,Chigusa Morizane,Yoshito Komatsu,Shunsuke Kondo,Makoto Ueno,Satoshi Kobayashi,Masayuki Furukawa,Lingaku Lee,Taroh Satoh,Daisuke Sakai,Masafumi Ikeda,Hiroshi Imaoka, Arisa Miura,Yutaka Hatanaka,Isao Yokota,Yoshiaki Nakamura,Takayuki Yoshino

Future oncology (London, England)no. 26 (2024): 1901-1907

Cited0Views0WOSBibtex

Phase II Study of S-1 Plus Docetaxel As First-Line Treatment for Older Patients with Advanced Gastric Cancer (OGSG 0902)

Tomono Kawase,Hiroshi Imamura,Ryohei Kawabata,Jin Matsuyama,Kazuhiro Nishikawa,Kazuhiro Yanagihara,Kazuyoshi Yamamoto,Noriyuki Hoki,Junji Kawada,Hisato Kawakami,Daisuke Sakai,Yukinori Kurokawa,Toshio Shimokawa,Taroh Satoh

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGYno. 2 (2024): 134-141

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn